.Merck beats profits desires, increases sales outlook on strong demand for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Forecasts as Keytruda Sales Growth BloombergMerck Inventory: Pharma Giant Posts Strong Outcomes, Yet Overview Tumbles Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings and also sales expectations among Keytruda asset, yet gives mixed full-year overview MarketWatch.